Bios
VC firm · Fort Worth, TX
Verified active in the last 12 monthsSEC-registered adviser
Venture firm based in Fort Worth, TX. Most recent fund on file: Bios Special Opportunity Fund II, LP ($7.4M offering), filed Apr 2023. 3 deal vehicles (SPVs) filed with the SEC since Jul 2024.
- Stages
- Pre-seed, Seed
- Typical check (est.)
- $75K–$200K
- Latest fund
- $50M · Aug 2023
- Last verified activity
- Mar 2026
Focus
Biotech & PharmaHealthcareAI & MLRecent portfolio activity
- May 2025
Trefoil Therapeutics
Board seat · CA
Funds and vehicles on SEC file
- Mar 2026
Bios 2026 Co-Invest, LP
Deal vehicle · $3.41M offering
- Jun 2025
Bios i-Lumen Co-Invest I, LP
Deal vehicle · $2.46M offering
- Jul 2024
Bios ONL Co-Invest II, LP
Deal vehicle · $7.21M offering
- Jul 2024
Bios 2024 Co-Invest, LP
Deal vehicle · $6.28M offering
- Aug 2023
Bios Clinical Opportunity Fund, LP
Fund · $50M offering
- Apr 2023
Bios Special Opportunity Fund II, LP
Fund · $7.39M offering
Sources
- SEC Form D: Bios 2026 Co-Invest, LPMar 20, 2026
- SEC Form D: Bios ONL Co-Invest II, LPJul 1, 2024
- SEC Form D: Bios 2024 Co-Invest, LPJul 1, 2024
- SEC Form D: Bios Special Opportunity Fund II, LPApr 6, 2023
- SEC adviser record: Bios Capital Management, LPMar 30, 2026
- Firm websiteOct 12, 2026
- SEC Form D: Bios Clinical Opportunity Fund, LPAug 4, 2023
- SEC Form D: Bios i-Lumen Co-Invest I, LPJun 16, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.